Inaba Munemichi, Noguchi Yuichi, Yamamoto Taro, Imai Tomihiko, Hatano Masako, Yagi Shinji, Katayama Shigehiro
Fourth Department of Medicine, Saitama Medical School, 38 Morohongo, Moroyama-cho, Iruma-gun, Saitama 350-0495, Japan.
Hypertens Res. 2004 Mar;27(3):141-5. doi: 10.1291/hypres.27.141.
To investigate the effects of the diuretic, indapamide, on blood pressure (BP) and metabolic parameters, thirty hypertensive patients were treated with 1 mg of indapamide either every day or every other day. BP, fasting plasma glucose, lipids, serum potassium and uric acid were determined at baseline and after 3 months of a stable regimen of the drug. At the termination of the study, 48-h ambulatory blood pressure monitoring (ABPM) was performed. Three patients received only indapamide, while other patients were treated in combination with additional antihypertensive medications. Patients treated with daily indapamide showed a BP reduction from 162 +/- 2.9/85 +/- 2.4 mmHg to 134 +/- 2.4/71 +/-2.6 mmHg (p < 0.001). The BP reduction was similar in those patients receiving the drug every other day (137 +/- 3.4/71 +/- 3.6 mmHg). While plasma lipids and serum potassium did not differ significantly with the intervention, uric acid increased significantly with daily treatment and normalized with every-other-day treatment. Glycosylated hemoglobin A1c (HbA1c) was not altered (5.6 +/- 0.1% vs. 5.4 +/- 0.2%), and did not differ between patients with and without diabetes mellitus. ABPM revealed an average 24-h BP of 134 +/- 3.3/75 +/- 1.7 mmHg on days in which patients received the medication and 139 +/- 4.9/78 +/- 2.6 mmHg on the intervening day without indapamide (no significant difference). These results suggest that a low dose of indapamide given every day or every other day is effective in lowering BP and does not result in metabolic derangements.
为研究利尿剂吲达帕胺对血压(BP)和代谢参数的影响,30例高血压患者每天或隔天服用1mg吲达帕胺进行治疗。在基线期以及药物稳定治疗3个月后,测定血压、空腹血糖、血脂、血清钾和尿酸。研究结束时,进行了48小时动态血压监测(ABPM)。3例患者仅接受吲达帕胺治疗,其他患者则联合使用其他抗高血压药物进行治疗。每日服用吲达帕胺的患者血压从162±2.9/85±2.4mmHg降至134±2.4/71±2.6mmHg(p<0.001)。隔天服用该药的患者血压下降情况相似(137±3.4/71±3.6mmHg)。虽然干预后血脂和血清钾无显著差异,但每日治疗后尿酸显著升高,隔天治疗后尿酸恢复正常。糖化血红蛋白A1c(HbA1c)未改变(5.6±0.1%对5.4±0.2%),糖尿病患者与非糖尿病患者之间也无差异。ABPM显示,患者服药日的平均24小时血压为134±3.3/75±1.7mmHg,未服用吲达帕胺的间隔日平均血压为139±4.9/78±2.6mmHg(无显著差异)。这些结果表明,每天或隔天给予低剂量吲达帕胺可有效降低血压,且不会导致代谢紊乱。